Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

ChainsTypeFamily Name Domain Identifier Family IdentifierProvenance Source (Version)
ASCOP2B SuperfamilyEF-Tu post-G domain-like 8056352 3002024 SCOP2B (2022-06-29)
ASCOP2B SuperfamilyEF-Tu post-G domain-like 8056350 3002024 SCOP2B (2022-06-29)
ASCOP2B SuperfamilyRas-like P-loop GTPases 8056349 3002022 SCOP2B (2022-06-29)
B [auth C]SCOP2B SuperfamilyElongation factor Ts (EF-Ts), dimerisation domain 8035038 3000908 SCOP2B (2022-06-29)
B [auth C]SCOP2B SuperfamilyElongation factor Ts (EF-Ts), dimerisation domain 8032444 3000908 SCOP2B (2022-06-29)
B [auth C]SCOP2B SuperfamilyUBA-like 8032443 3001235 SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
AGTP_EFTU_D2_1e4pc7A3 A: beta barrelsX: cradle loop barrelH: RIFT-relatedT: Alanine racemase-CF: GTP_EFTU_D2_1ECOD (1.6)
AGTP_EFTU_D3e4pc7A1 A: beta barrelsX: cradle loop barrelH: RIFT-relatedT: Aminomethyltransferase beta-barrel domainF: GTP_EFTU_D3ECOD (1.6)
AMnmE_helical_2nde4pc7A2 A: a/b three-layered sandwichesX: P-loop domains-likeH: P-loop domains-relatedT: P-loop containing nucleoside triphosphate hydrolasesF: MnmE_helical_2ndECOD (1.6)
B [auth C]UBA_4e4pc7C2 A: alpha arraysX: RuvA-CH: RuvA-C, UBA, CRAL/TRIO-N, HBS1 (From Topology)T: RuvA-C, UBA, CRAL/TRIO-N, HBS1F: UBA_4ECOD (1.6)
B [auth C]EF_TSe4pc7C3 A: a+b two layersX: T-foldH: Elongation factor Ts (EF-Ts), dimerisation domain (From Topology)T: Elongation factor Ts (EF-Ts), dimerisation domainF: EF_TSECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Protein Family Annotation Pfam Database Homepage

ChainsAccessionNameDescriptionCommentsSource
PF00009Elongation factor Tu GTP binding domain (GTP_EFTU)Elongation factor Tu GTP binding domainThis domain contains a P-loop motif, also found in several other families such as Pfam:PF00071, Pfam:PF00025 and Pfam:PF00063. Elongation factor Tu consists of three structural domains, this plus two C-terminal beta barrel domains.Domain
PF03143Elongation factor Tu C-terminal domain (GTP_EFTU_D3)Elongation factor Tu C-terminal domainElongation factor Tu consists of three structural domains, this is the third domain. This domain adopts a beta barrel structure. This the third domain is involved in binding to both charged tRNA [1] and binding to EF-Ts Pfam:PF00889 [2].Domain
PF03144Elongation factor Tu domain 2 (GTP_EFTU_D2)Elongation factor Tu domain 2Elongation factor Tu consists of three structural domains, this is the second domain. This domain adopts a beta barrel structure. This the second domain is involved in binding to charged tRNA [1]. This domain is also found in other proteins such as e ...Elongation factor Tu consists of three structural domains, this is the second domain. This domain adopts a beta barrel structure. This the second domain is involved in binding to charged tRNA [1]. This domain is also found in other proteins such as elongation factor G and translation initiation factor IF-2. This domain is structurally related to Pfam:PF03143, and in fact has weak sequence matches to this domain.
Domain
B [auth C]PF00889Elongation factor TS (EF_TS)Elongation factor TS- Family

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

ChainsPolymerMolecular FunctionBiological ProcessCellular Component
Elongation factor Tu 1
B [auth C]Elongation factor Ts

Structure Motif Annotation: Mechanism and Catalytic Site Atlas M-CSA Database Homepage

ChainsEnzyme NameDescriptionCatalytic Residues
protein-synthesizing GTPase (elongation factor Tu)  M-CSA #535

Elongation factor Tu hydrolyses GTP to give GDP and Pi, thus providing the free energy that the ribosome needs to incorporate amino acids into the growing polypeptide. As such, it shows homology to other GTP binding proteins such as the oncogene ras, but may show a different mechanism of GTP hydrolysis. Many antibiotics are able to inhibit EFTu, making study of its mechanism particularly useful in view of the possibility of synthesising new antibiotics.

Defined by 4 residues: ASP:A-22 [auth A-21]LYS:A-25 [auth A-24]THR:A-26 [auth A-25]HIS:A-85 [auth A-84]
 | 
 
Explore in 3DM-CSA Motif Definition